Cleared Traditional

K121768 - COSENSE

K121768 is an FDA 510(k) clearance for COSENSE, manufactured by Capnia, Inc.. The device is a Class 2 Anesthesiology device with product code CCJ cleared through the Traditional 510(k) pathway after a 138-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2012
Decision
138d
Days
Class 2
Risk

K121768 is an FDA 510(k) clearance for the COSENSE. Classified as Analyzer, Gas, Carbon-monoxide, Gaseous-phase (product code CCJ), Class II - Special Controls.

Submitted by Capnia, Inc. (Palo Alto, US). The FDA issued a Cleared decision on October 31, 2012 after a review of 138 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1430 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Capnia, Inc. devices

FDA 510(k) Submission Details - K121768

510(k) Number K121768 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 15, 2012
Decision Date October 31, 2012
Days to Decision 138 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
2d faster than avg
Panel avg: 140d · This submission: 138d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCJ Device Classification - Class 2, Special Controls

Product Code CCJ Analyzer, Gas, Carbon-monoxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1430
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCJ Analyzer, Gas, Carbon-monoxide, Gaseous-phase

All 11
Devices cleared under the same product code (CCJ) and FDA review panel - the closest regulatory comparables to K121768.
Pivot Breath Sensor
K201206 · Carrot, Inc. · Jun 2021
ToxCO
K173238 · Bedfont Scientific, Ltd. · Apr 2019
CO Check Pro, CO Screen
K171129 · MD Diagnostics Limited · Mar 2018
CO TEST
K843845 · Erich Jaeger, Inc. · Oct 1984
CD-102 CARBON DIOXIDE ANALYZER/RECOR
K833739 · Instrumentarium Corp. · Dec 1983
ECOLYZER #200/COHB ANALYZER SYS
K832655 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Sep 1983